Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

Read More »

July 2, 2025

Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD

Read More »

July 2, 2025

Redhill Biopharma Starts Recruitment For Phase 2 Opaganib/darolutamide Combo Study In Advanced Prostate Cancer

Read More »

July 2, 2025

OneOncology, HOATC Partner to Advance Cancer Care in Florida

Read More »

June 30, 2025

ESTEVE To Acquire Medicine To Treat Medullary Thyroid Cancer

Read More »

June 30, 2025

Porton and EVA Pharma Partner to Expand CAR T-Cell Therapy Access

Read More »

June 26, 2025

Icon Group, Varian Partner to Expand Cancer Tech in the UK

Read More »

June 26, 2025

Ambry CARE Program Validated for Hereditary Cancer Risk

Read More »

June 26, 2025

A.C. Camargo Boosts Patient Care with Video Surveillance

Read More »

June 25, 2025

Bio-Thera Begins Phase 3 Trial for BAT8006 in Ovarian Cancer

Read More »

June 25, 2025